← Back to DSGN

Design Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 03/08/2026Mar 2026Filed 28/04/2026Sep 2025Filed 05/11/2025Jun 2025Filed 03/08/2026Mar 2025Filed 28/04/2026Sep 2024Filed 05/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 07/05/2025
$0$0
−$20−$18−$17−$19−$18−$13−$12−$11
−$0.32−$0.29−$0.30−$0.34−$0.31−$0.23−$0.21−$0.20
6361575757575756

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.